ideal for precise characterization. Imaging can be performed with a combination of phases depending on the indication. These phases include the early arterial phase (20-30 seconds after IV contrast administration), the pancreatic parenchymal phase (35-50 seconds after IV contrast administration), and the portal venous phase (60-70 seconds after IV contrast administration). Most nonvascular hypervascular abnormalities are best depicted in the pancreatic parenchymal phase. Acquiring images at the optimal time is critical and can be achieved by administering a test bolus of contrast material or by using bolus-tracking techniques [2] .
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Imaging Appearances of Hemorrhage
Acute hemorrhage typically has high attenuation on unenhanced MDCT scans. As the hematoma ages, its attenuation value decreases. The appearance of blood on MR images is highly variable depending on the age of the hematoma and the imaging sequence used [1] . With time, hemoglobin evolves through several forms. Each type of hemoglobin has a specific imaging characteristic. These appearances have been primarily described with regard to intracranial hemorrhage [1] and may not extrapolate directly to intraabdominal hemorrhage. Subacute hemorrhage is typically hyperintense on T1-weighted images and hypointense or hyperintense on T2-weighted images. Because of the hemosiderin content, chronic hematoma can be hypointense on both T1-and T2-weighted images.
Neoplastic Conditions Endocrine Pancreatic Tumors
Endocrine pancreatic tumors originate from the islet cells of Langerhans that make up the endocrine pancreas. These tumors are rare with a reported incidence of five cases per million persons per year [4] . All endocrine tumors are hormonally active to a variable degree but are typically divided into syndromic (hyperfunctioning, 85%) and nonsyndromic (nonhyperfunctioning, 15%) depending on the clinical and biochemical manifestations [5] . Endocrine tumors can be further classified according to the cell type from which they originate. The cell type determines the predominant hormone secreted by the tumor. Examples of syndromic endocrine tumors in decreasing order of frequency are insulinoma (60%), gastrinoma (20%), glucagonoma (3%), VIPoma (2%), and somatostatinoma (less than 1%) [5] . Syndromic tumors tend to come to medical attention early because of the clinical manifestations of the hormone secreted and tend to be relatively small at diagnosis. Nonsyndromic tumors manifest later, at a larger size, and the clinical symptoms are usually related to mass effect [6] . The malignant potential of insulinoma is low, ranging from 6% to 10%. The other syndromic tumors, however, are more frequently malignant [6] .
Imaging of endocrine pancreatic tumors can be challenging to radiologists. Insulinoma is located with an equal distribution in the head, body, and tail of the pancreas. Gastrinoma, however, is located in the gastrinoma triangle formed by the cystic duct confluence, the junction of the neck and body of the pancreas, and the junction of the second and third parts of the duodenum [7] . VIPoma can be extrapancreatic in 10-20% of cases, and somatostatinoma is duodenal in 50% of cases [6] . The size of the tumors is variable; for example, 90% of insulinomas are smaller than 2 cm in diameter, whereas glucagonoma usually is large, having a mean diameter of 6.5 cm [5] . Unenhanced cross-sectional imaging may provide useful information. Areas of necrosis, cystic change, or calcification can be found at MDCT. Insulinoma occasionally has high attenuation on unenhanced MDCT scans [8] . In addition, at MRI, the tumor is usually hypointense on T1-weighted images and hyperintense on T2-weighted images [7] . The key to diagnosis, however, lies in the rich vascular supply of the tumor. A vascular blush on contrast-enhanced MDCT scans or MR images is characteristic ( Figs. 1 and 2) .
The optimal phase of acquisition is still contentious. The aim of contrast-enhanced imaging is to maximize the contrast between the tumor and the pancreatic parenchyma. The contrast usually is greatest in the late arterial or pancreatic parenchymal phase [9] ; however, the portal venous phase has been reported to be more reliable in certain cases [10] . Biphasic scanning therefore is advocated with images obtained in both the late arterial and portal venous phases.
Serous Microcystic Pancreatic Adenoma
Serous microcystic pancreatic adenoma, with the exception of rare cystic endocrine tumors, is the only hypervascular cystic pancreatic neoplasm, an important discriminatory feature for diagnosis. Intratumoral hemorrhage also has been reported to occur [11, 12] . Serous microcystic pancreatic adenoma is a benign neoplasm that occurs most commonly in women older than 60 years. Is has a predilection for the pancreatic head but can be found in all parts of the pancreas [13] . An association exists with von Hippel-Lindau disease. The classic histopathologic signature is multiple cysts (more than six), which individually measure less than 2 cm in diameter. A macrocystic or oligocystic variant, however, is composed of fewer and larger cysts [12] .
On images, serous microcystic pancreatic adenoma has a lobulated appearance. It has low attenuation on unenhanced MDCT scans and high signal intensity on T2-weighted MR images, reflecting the cystic composition. High signal intensity on fat-suppressed T1-weighted images represents hemorrhage. A stellate fibrous central scar may be present and can calcify. After contrast administration, there is early and vivid enhancement of the fibrous components, which may be persistent on delayed images (Figs. 3 and 4) .
Solid Pseudopapillary Tumor
Solid pseudopapillary tumor is a rare pancreatic cystic tumor that occurs almost exclusively in young women. It is usually benign or of low-grade malignancy and therefore has a slow growth rate [13] . Histologically, it is encapsulated [14] . In addition, intratumoral hemorrhage is common and has been reported in 74-98% of cases [14, 15] . These two features can be identified on images and help discriminate solid pseudopapillary tumor from other pancreatic neoplasms. MDCT classically shows a well-encapsulated lesion with mixed solid and cystic components, which result from hemorrhagic degeneration (Fig. 5 ). Calcifications and solid areas may be seen peripherally. After contrast administration, the solid tissue and capsule become enhanced to a lesser degree than the surrounding pancreas [16] . MRI also shows a well-defined mass with a heterogeneous appearance on both T1-and T2-weighted images. Areas of hemorrhage are hyperintense on fat-suppressed T1-weighted images and hypointense on T2-weighted images (Fig. 6 ). Images show early peripheral enhancement with progressive heterogeneous incomplete fill-in in later phases [14] .
Acinar Cell Carcinoma
Acinar cell carcinoma is a rare neoplasm that originates from the acinar elements of the exocrine pancreas. Histologically, hemorrhage often is present within the tumor [17] . Acinar cell carcinoma makes up only 1% of pancreatic exocrine tumors and has a slightly better prognosis than ductal adenocarcinoma [18] . The tumor cells can produce excessive pancreatic enzymes, in particular lipase, in 10% of patients, resulting in lipase hypersecretion syndrome, which manifests itself as subcutaneous fat necrosis, polyarthritis, and bone infarcts [5] . The MDCT and MRI appearance of acinar cell carcinoma is an exophytic, well-marginated mass [18] , which is usually solid when small but contains hemorrhagic, necrotic areas as it enlarges. Enhancement is generally homogeneous but less than that of the surrounding pancreatic parenchyma [18] (Fig. 7) .
Metastatic Tumors
Metastatic lesions to the pancreas are rare and usually occur at an advanced stage. Most
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metastatic lesions have low attenuation in relation to normal pancreatic parenchyma on unenhanced MDCT scans. On MR images these lesions are hypointense on T1-weighted images and moderately hyperintense on T2-weighted images [5] . Contrast enhancement of pancreatic metastatic lesions is variable and can simulate the enhancement characteristics of the primary tumor on contrast-enhanced MDCT or MRI [19] . Metastatic lesions from renal cell carcinoma, melanoma, thyroid carcinoma, and sarcoma are classically hypervascular and can appear as hyperenhancing lesions [5] (Fig. 8 ).
Inflammatory and Vascular Conditions Hemorrhagic Pancreatitis
Pancreatic necrosis occurs in approximately 20% of cases of acute pancreatitis [20] . This disorder can be associated with hemorrhagic changes affecting the pancreatic parenchyma and the extrapancreatic fatty tissue. Mortality in hemorrhagic pancreatitis is variable and reported to range from 33% to 100% [21] . Autodigestion by extravasated pancreatic enzymes results in venule and capillary disruption [22] . The bleeding that ensues is usually self-limited, but marked hemorrhage can occur in 2-5% of patients with acute pancreatitis [23] . High-attenuation material within the pancreatic bed on unenhanced CT scans and high signal intensity on fat-suppressed T1-weighted images correlate with the presence of blood products (Figs. 9 and 10). Pseudocysts also may exhibit hemorrhage [24] (Fig. 11) .
Peripancreatic Pseudoaneurysm
Pseudoaneurysm formation occurs in as many as 10% of cases of pancreatitis [20] . The time interval is variable, ranging from days to years after the acute episode. The most common vessels affected are the splenic and gastroduodenal arteries. Early detection and management are paramount given the high mortality associated with rupture. Rupture can occur into the peritoneum, adjacent hollow organs, pseudocyst, or pancreatic duct (hemosuccus pancreaticus) [25] . Dedicated MDCT or MR angiography can elegantly depict the pseudoaneurysm as a well-delineated rounded structure originating from the donor artery [26] . High-attenuation or high-signalintensity thrombus may be seen within the sac on unenhanced CT scans and fat-suppressed T1-weighted MR images. After contrast administration, the sac may fill with contrast material if it is not completely thrombosed (Fig. 12) . If juxtapancreatic in location, a pseudoaneurysm can mimic a hypervascular lesion (Fig. 13) . Conventional angiography remains the standard of reference and provides the capability of endovascular management.
Portomesenteric Venous Thrombosis
A range of conditions can result in thrombosis of the portomesenteric venous system. These conditions include abdominal infection, pancreatitis, neoplasms, hypercoagulable states, and cirrhosis with portal hypertension. Because of its proximity to the organ, acute thrombosis of the splenic vein or superior mesenteric vein in particular can mimic a hemorrhagic pancreatic lesion. Important diagnostic features that help in discrimination are usually the lack of enhancement and the tubular configuration of the thrombosed vessel (Figs. 14 and 15). Care should be taken, however, in the interpretation of portal venous thrombosis secondary to malignant neoplasms, such as hepatocellular carcinoma and cholangio carcinoma. Unlike nonneoplastic (bland) thrombus, this tumor thrombus classically exhibits neovascularity and enhancement [27, 28] . Other features that help in differentiation of benign and malignant thrombus are direct invasion of the portal vein by the tumor and portal venous expansion of 23 mm or more [27] .
Peripancreatic Varices
There are multiple causes of portal hypertension. Regardless of the cause, multiple sites of portosystemic collateralization can decompress the increased portal pressure. In the region of the pancreatic head, pancreaticoduodenal varices can develop and simulate a pancreatic hypervascular lesion (Fig. 16 ). Findings at MDCT or MRI performed with meticulous technique can lead to accurate diagnosis. Dedicated MDCT and MR angiography with 3D multiplanar reformations are useful for visualizing these vessels, which are characterized by a tubular and tortuous configuration. Enhancement is best in the portal venous rather than the arterial phase [29] . Identification of the other features of portal hypertension, such as splenomegaly and ascites, adds to diagnostic confidence.
Miscellaneous Conditions Trauma
Pancreatic injury can result from blunt (27%) and penetrating (73%) trauma [30] (Fig. 17) . In addition, iatrogenic causes such as biopsy and surgery can result in injury (Fig.  18) . The primary method of evaluation is contrast-enhanced MDCT. A spectrum of imaging findings can occur that include pancreatic hematoma, laceration, transection, and diffuse gland enlargement. Extrapancreatic findings such as peripancreatic fat stranding, hematoma, and fluid also can be identified [31] . The integrity of the pancreatic duct can be assessed with secretin-enhanced MR cholangiopancreatography or ERCP.
Secretin-enhanced MR cholangio pancreato graphy involves dynamic MR pancreatography after IV stimulation with human or porcine secretin (0.2 µg/kg body weight). The secretin stimulation leads to stimulation of the exocrine pancreatic gland. It also temporarily increases the tone of the sphincter of Oddi during the first minutes after injection, inhibiting release of fluid through the papilla of Vater. The tone then decreases [32] . Secretin therefore initially improves delineation of the pancreatic duct. Secretin-enhanced MR cholangio pancreatography can depict ductal disruption and active leaks. Unlike ERCP, it can depict the duct distal to the injury. This capability is useful for planning intervention. In addition, the technique is useful for evaluation of the pancreatic parenchyma and peripancreatic collections [33] .
Accessory Spleen
Accessory spleen is common, being found at 10-30% of autopsies. The location of accessory spleen is variable, 21.8% being located near or within the pancreatic tail [34] . As a consequence, accessory spleen can be misdiagnosed as a hypervascular pancreatic mass. At CT or MRI, an accessory spleen should have the same attenuation or signal intensity as the main spleen. In addition, an accessory spleen becomes enhanced to the same degree as the main spleen with both techniques (Figs. 19 and 20) . If CT and MRI findings continue to be equivocal, nuclear scintigraphy can be performed with 99m Tclabeled sulfur colloid or 99m Tc-labeled heatdamaged RBCs. The successful diagnosis of intrapancreatic accessory spleen with MRI with reticuloendothelial system-specific contrast agents has been reported [35] .
Pitfalls
Duodenal Diverticulum
Duodenal diverticula are located most frequently in the periampullary region along the medial aspect of the second and third portions of the duodenum. When filled with fluid they can mimic cystic lesions of the pancreatic head [36] . They also can simulate hypervas-Sahni and Mortelé cular pancreatic lesions and peripancreatic pseudoaneurysm if filled with oral contrast material (Fig. 21 ). Identifying gas within the diverticulum or persistent high density on delayed images can clarify the situation. Gas causes a susceptibility blooming artifact on spoiled GRE MR images that can be identified in the sequence with the longer TE in dual-echo chemical shift imaging.
Metastasis of Melanoma
Metastasis to the pancreas from malignant melanoma has been found in as many as 37.5% of autopsy cases [37] . Metastatic lesions from melanoma are hyperintense on T1-weighted images and hypointense on T2-weighted images (Fig. 22) . This manifestation is caused by the paramagnetic properties of melanin within the lesion, which shorten the T1 and T2 relaxation times [38] . The appearance on MRI is indistinguishable from that of a hemorrhagic lesion containing methemoglobin. This dif ference is important to appreciate, because metastasis to the pancreas from melanoma may be the only site of metastatic disease [39] and should be considered if a hyperintense lesion is identified on T1-weighted images. Subtraction imaging can be useful in identifying enhancement in lesions that are hyperintense on unenhanced T1-weighted images. The process involves subtracting T1-weighted unenhanced images from T1-weighted contrast-enhanced images. Note should be made of the amelanotic subtype of melanoma. The lesion can be isointense or hypointense on T1-weighted images owing to the reduced percentage of melanin-containing cells compared with conventional metastatic lesions from melanoma [40] .
Conclusion
Pancreatic hypervascular conditions are common and easily detected on multiphasic contrast-enhanced MDCT and MR images. Unenhanced CT and, especially, fat-suppressed T1-weighted MRI, are valuable for detecting hemorrhage within pancreatic abnormalities. Familiarity with the spectrum of possible underlying causes and the imaging features and conditions that can act as mimics assists radiologists in making an accurate presumptive diagnosis in most cases. 
